Market Overview

SenesTech Files Request with EPA for the Removal of "Restricted Use Only" for ContraPest®


SenesTech Files Request with EPA for the Removal of "Restricted Use Only" for ContraPest®

PR Newswire

FLAGSTAFF, Ariz., Aug. 2, 2018 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced that it has requested that the U.S. Environmental Protection Agency consider the reclassification of ContraPest® from 'Restricted Use' to a 'General Use' pesticide. Action on this request is pending.

SenesTech, Inc. is a leader in technology for managing animal pest populations through fertility control. (PRNewsfoto/SenesTech, Inc.) (PRNewsfoto/SenesTech, Inc.)

ContraPest was registered as a "Restricted Use" product (RUP) due to the need for applicator expertise to deploy and service the product. This designation means that a pest management professional (PMP) must, in many states, be specially licensed for restricted use products, and is subject to additional regulation.  Having gained experience using the product, the Company has decided to provide information to support the request for removal, to accelerate the adoption of ContraPest. The Company is submitting letters of support from the industry, including from some of the largest PMP firms.

"The number one objection we receive from pest management professionals considering the adoption of ContraPest is that the RUP label is cumbersome and inexplicable. As a result, 30-50% of PMPs are unable or unwilling to deploy Restricted Use Pesticides as a matter of policy and practice. Removing this designation would double our market potential immediately through an easier sales process and ultimately broader market acceptance of our product," said Joe Malinowski, Vice President of Sales for SenesTech.

About ContraPest 

ContraPest® is an innovative technology that targets the reproductive capabilities of Norway and roof rats. As a highly palatable liquid, the formulation promotes sustained consumption, helping to reduce fertility in both male and female rats, bringing populations down and keeping them down. Our delivery system is designed to minimize handler exposure, and ContraPest is dispensed inside tamper resistant bait stations, minimizing the risks to non-target species.

As a versatile tool, ContraPest can be used within Integrated Pest Management (IPM) programs to help reduce reproduction and magnify the success of IPM protocols or as a standalone, non-lethal solution for customers that are looking to reduce or eliminate the use of lethal methodologies.

ContraPest is a Restricted Use Pesticide, due to applicator expertise. Please read and comply with all label instructions.

About SenesTech

SenesTech has developed and is in the process of commercializing a proprietary technology for managing animal pest populations, primarily rat populations, through fertility control. For more information visit the SenesTech website at

Safe Harbor Statement

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" involve estimates, assumptions, risks and uncertainties and describe future expectations, plans, results, or strategies. Forward looking statements are generally preceded by words such as "may," "future," "believe," "plan," "will" or "should," "continue," "expect," "anticipates," "eventually," "projected" or other comparable terminology. Such forward looking statements include, but are not limited to: our expectations regarding the effect of removal of the restricted use label on our market potential, sales process and market acceptance of our products. You should not unduly rely on forward looking statements because such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors and other risks identified in our filings with the Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.


Investor: Robert Blum, Joe Dorame, Joe Diaz, Lytham Partners, LLC, 602-889-9700,

Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., 928-779-4143


Cision View original content with multimedia:

SOURCE SenesTech, Inc.

View Comments and Join the Discussion!